MADRID -- Digitoxin added to guideline-directed medical therapy improved outcomes among patients with heart failure and reduced ejection fraction (HFrEF), the DIGIT-HF trial showed. The cardiac ...
MADRID, Spain—Adding digitoxin, a cardiac glycoside, to contemporary guideline-directed medical therapy (GDMT) improves clinical outcomes in patients who have heart failure with reduced ejection ...
"Our study is one of very few that shows a relationship between prophylactic cardiac medication use and survival in DMD…This is a strong addition to the existing literature supporting early initiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback